~~<i id='2A80237297'><strike id='2A80237297'><tt id='2A80237297'><pre id='2A80237297'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：focus 2025-09-28 00:52:13 - browse：34

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Biotech stock slump in 2023: awaiting the turnaround

entertainment

Wikipedia

entertainment

knowledge

hotspot

entertainment

Editor’snote:Alivestreamoftheeventisembeddedbelow.Enoughtalkaboutfairness,safety,andeffective

WSS

CDC advisers recommend seasonal use of Pfizer RSV shot

Drug for rare kidney disease narrowly misses mark in clinical trial

NIH confirmation hearing shows politicization of research

Hospital price transparency does save money, advocate argues

Ukraine and a new approach to mental health in war

Why are Kaiser Permanente staff considering a strike?

hotspot

entertainment

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

It's been 20 years since Dolly the sheep. Where's my clone?

New air purifier tech could be key to improving indoor air quality

Drug for rare kidney disease narrowly misses mark in clinical trial

Alkermes shareholders re

How AI helped researchers track recovery from depression

Anesthesiologist group: stop taking Ozempic before surgery

HHS leader on health, climate change and biopharma emissions

In Memoriam: Notable people who died in 2023

Medicare reduced heart disease by changing how it pays doctors

Wikipedia

Senate committee scrutinizes Medicare Advantage brokers

Thermo Fisher plant for manufacturing gene therapies to expand

FDA warns J&J's Abiomed: We will regulate your software

Microbiome research is starting to find links to chronic diseases

Senate HELP committee spars over health care workforce policies

How AI helped researchers track recovery from depression

entertainment

knowledge

hotspot

entertainment